The balance between pro- and anti-inflammatory cytokines is crucial in human allergic contact dermatitis pathogenesis: The role of IL-1 family members

Experimental Dermatology

Volumn 22, Issue 12, 2013, Pages 813-819

  Mattii, Martina ^a   Ayala, Fabio ^a   Balato, Nicola ^a   Filotico, Raffaele ^b   Lembo, Serena ^a   Schiattarella, Maria ^a   Patruno, Cataldo ^a   Marone, Gianni ^a   Balato, Anna ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b PERRINO HOSPITAL   (Italy)

Author keywords

Allergic contact dermatitis; IL 1; IL 1 family; IL 33; IL 36

Indexed keywords

ALLERGEN; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 11; INTERLEUKIN 33; INTERLEUKIN 36; NICKEL; UNCLASSIFIED DRUG;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTACT DERMATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATION; LYMPHOCYTE; PATCH TEST; PATHOGENESIS; SENSITIZATION; SKIN ALLERGY; SKIN BIOPSY;

ALLERGIC CONTACT DERMATITIS; IL-1; IL-1 FAMILY; IL-33; IL-36;

ADULT; BIOPSY; CYTOKINES; DERMATITIS, ALLERGIC CONTACT; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-8; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; RECOMBINANT PROTEINS; SKIN;

EID: 84888315696     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12272     Document Type: Article

References (61)

1. Kaplan D H, Igyártó B Z, Gaspari A A. Nat Rev Immunol 2012: 12: 114-124.
2. Martin S F, Esser P R, Weber F C et al. Allergy 2011: 66: 1152-1163.
3. Larsen J M, Bonefeld C M, Poulsen S S et al. J Allergy Clin Immunol 2009: 123: 486-492.
4. Peiser M, Tralau T, Heidler J et al. Cell Mol Life Sci 2012: 69: 763-781.
5. Gober M D, Fishelevich R, Zhao Y et al. J Invest Dermatol 2008: 128: 1460-1469.
6. Dinarello C A. Blood 2011: 117: 3720-3732.
7. Sims J E, Smith D E. Nat Rev Immunol 2010: 10: 89-102.
8. Ohno T, Oboki K, Morita H et al. PLoS One 2011: 6: e18404.
9. Aliahmadi E, Gramlich R, Grutzkau A et al. Eur J Immunol 2009: 39: 1221-1230.
10. Cumberbatch M, Dearman R J, Antonopoulos C et al. Immunology 2001: 102: 323-330.
11. Komai-Koma M, Gilchrist D S, McKenzie A N et al. J Immunol 2011: 186: 2584-2591.
12. Nakae S, Naruse-Nakajima C, Sudo K et al. Int Immunol 2001: 13: 1471-1478.
13. Kawase Y, Hoshino T, Yokota K et al. J Invest Dermatol 2003: 121: 502-509.
14. Antonopoulos C, Cumberbatch M, Mee J B et al. J Leukoc Biol 2008: 83: 361-367.
15. Christensen A D, Haase C. APMIS 2012: 120: 1-27.
16. Niebuhr M, Bäumer W, Kietzmann M et al. Exp Dermatol 2012: 21: 52-56.
17. Bonneville M, Chavagnac C, Vocanson M et al. J Invest Dermatol 2007: 127: 1430-1435.
18. Ertam I, Itirli G, Onay H et al. Contact Dermatitis 2009: 61: 86-90.
19. Gangemi S, Merendino R A, Minciullo P L et al. J Dermatol Sci 2003: 33: 187-188.
20. Corsini E, Mitjans M, Galbiati V et al. Toxicol In Vitro 2009: 23: 789-796.
21. Zhang J, Li L, Lu Q et al. J Dermatol 2010: 37: 512-521.
22. Fregert S. Manual of Contact Dermatitis, 2nd edn. Copenhagen: Munksgaard, 1981.
23. Ruifrok A C, Johnston D A. Anal Quant Cytol Histol 2001: 23: 291-299.
24. Trowell O A. Exp Cell Res 1954: 6: 246-248.
25. Ouwehand K, Scheper R J, de Gruijl T D et al. Eur J Immunol 2010: 40: 2026-2034.
26. Schmittgen T D, Zakrajsek B A. J Biochem Biophys Methods 2000: 46: 69-81.
27. Livak K J, Schmittgen T D. Methods 2001: 4: 402-408.
28. Johnston A, Xianying X, Guzman A M et al. J Immunol 2011: 186: 2613-2622.
29. Smith D E, Renshaw B R, Ketchem R R et al. J Biol Chem 2000: 275: 1169-1175.
30. Kumar S, McDonnell P C, Lehr R et al. J Biol Chem 2000: 275: 10308-10314.
31. Busfield S J, Comrack C A, Yu G et al. Genomics 2000: 66: 213-216.
32. Mulero J J, Pace A M, Nelken S Y et al. Biochem Biophys Res Commun 1999: 263: 702-706.
33. Balato A, Schiattarella M, Lembo S et al. Arch Dermatol Res 2013: 305: 255-262.
34. Balato A, Lembo S, Mattii M et al. Exp Dermatol 2012: 21: 892-894.
35. Steinstraesser L, Rittig A, Gevers K et al. Eplasty 2009: 9: e5.
36. Ouwehand K, Santegoets S J, Bruynzeel D P et al. Eur J Immunol 2008: 38: 3050-3059.
37. Enk A H, Angeloni V L, Udey M C et al. J Immunol 1993: 150: 3698-3704.
38. Cumberbatch M, Dearman R J, Kimber I. Immunology 1997: 92: 388-395.
39. Kermani F, Flint M S, Hotchkiss S A. Toxicol Appl Pharmacol 2000: 169: 231-237.
40. Shornick L P, De Togni P, Mariathasan S et al. J Exp Med 1996: 183: 1427-1436.
41. Martinon F, Tschopp J. Cell 2004: 117: 561-574.
42. Martin S F. Exp Dermatol 2012: 21: 382-389.
43. Schmidt M, Raghavan B, Müller V et al. Nat Immunol 2010: 11: 814-819.
44. Towne J E, Renshaw B R, Douangpanya J et al. J Biol Chem 2011: 286: 42594-42602.
45. Schmitz J, Owyang A, Oldham E et al. Immunity 2005: 23: 479-490.
46. Ali S, Huber M, Kollewe C et al. Proc Natl Acad Sci USA 2007: 104: 18660-18665.
47. Talabot-Ayer D, McKee T, Gindre P et al. Joint Bone Spine 2012: 79: 32-37.
48. Smith D E. Clin Exp Allergy 2010: 40: 200-208.
49. Dickel H, Gambichler T, Kamphowe J et al. Contact Dermatitis 2010: 63: 215-222.
50. Ulfgren A K, Klareskog L, Lindberg M. Acta Derm Venereol 2000: 80: 167-170.
51. Collington S J, Hallgren J, Pease J E et al. J Immunol 2010: 184: 6114-6123.
52. Spiekstra S W, Toebak M J, Sampat-Sardjoepersad S et al. Exp Dermatol 2005: 14: 109-116.
53. Byrne S N, Beaugie C, O'Sullivan C et al. Am J Pathol 2011: 179: 211-222.
54. Moussion C, Ortega N, Girard J P. PLoS One 2008: 3: e3331.
55. Eisenberg S P, Brewer M T, Verderber E et al. Proc Natl Acad Sci USA 1991: 88: 5232-5236.
56. Towne J E, Garka K E, Renshaw B R et al. J Biol Chem 2004: 279: 13677-13688.
57. Zhao Y, Balato A, Fishelevich R et al. Br J Dermatol 2009: 161: 1301-1306.
58. Blumberg H, Dinh H, Trueblood E S et al. J Exp Med 2007: 204: 2603-2614.
59. Balato A, Zhao Y, Harberts E et al. Exp Dermatol 2012: 21: 915-920.
60. Matsushita A, Seike M, Okawa H et al. Exp Dermatol 2012: 9: 714-715.
61. Röse L, Schneider C, Stock C et al. Exp Dermatol 2012: 21: 25-31.